The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Plus Therapeutics Inc’s recently made public that its Director Petersen Greg acquired Company’s shares for reported $20276.0 on May 15
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Plus Therapeutics Inc revealed its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Plus Therapeutics
Plus Therapeutics Inc’s recent filing unveils that its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep
Plus Therapeutics Inc’s filing revealed that its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep 13
In a filing, Plus Therapeutics Inc revealed its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep
In a filing, Plus Therapeutics Inc revealed its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep
Plus Therapeutics, Inc. (PTSV) stock prices were up an impressive 16.5% as of market close on April 21st, 2021, bringing
